The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Utility of novel dynamic clinical indices in patients (pts) enrolled in a phase I (Ph I) oncology trial as markers of prognosis and treatment benefit.
J. E. Ang
No relevant relationships to disclose
D. Olmos
No relevant relationships to disclose
V. Moreno Garcia
No relevant relationships to disclose
A. Brunetto
No relevant relationships to disclose
D. Papadatos-Pastos
No relevant relationships to disclose
H. Arkenau
No relevant relationships to disclose
M. Blanco
No relevant relationships to disclose
R. D. Baird
No relevant relationships to disclose
P. A. Cassier
No relevant relationships to disclose
D. S. W. Tan
No relevant relationships to disclose
R. S. Kristeleit
No relevant relationships to disclose
S. Dolly
No relevant relationships to disclose
K. J. Shah
No relevant relationships to disclose
B. Amin
No relevant relationships to disclose
B. G. Anghan
No relevant relationships to disclose
L. R. Molife
No relevant relationships to disclose
U. Banerji
No relevant relationships to disclose
J. S. De Bono
No relevant relationships to disclose
S. B. Kaye
No relevant relationships to disclose